A 23-year-old female patient presented with anxiety, insomnia, hirsutism, skin pigmentation, obesity, and muscle weakness for 7 months. The results of serum ACTH, low-dose dexamethasone suppression tests (DSTs), high-dose DSTs, and inferior petrosal sinus sampling implicated that the symptoms might be caused by ectopic Cushing syndrome (ECS), due to the secretion of adrenocorticotropin hormone (ACTH) or corticotropin-releasing hormone (CRH). In order to locate the ectopic origin, the patient underwent Ga-DOTATATE PET/CT imaging(a-d) revealed one lesion on pancreas (d, arrow) and multiple lesions on liver. While the pancreas showed no abnormality on 18 F-FDG PET/CT imaging (e-h, arrow), and the lesions on the liver were fewer and smaller than that on 68 Ga-DOTATATE. Neuroendocrine tumors (NET, Ki67 > 15%) were confirmed by histopathological results of biopsy on liver and pancreas. Immunohistochemical analysis was positive for CRH and negative for ACTH.
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The clinical presentations of ectopic CRH syndrome might be similar to that of ectopic ACTH syndrome, so the differential diagnosis of these two diseases is important. Commonly, the tumors associated with ectopic CRH secretion are pheochromocytoma, medullary thyroid carcinoma, and prostate cancer [1] . Ectopic ACTH and CRH co-secreting tumor and ectopic ACTH secreting tumor detected by 68 Ga-DOTA-peptide PET/CT were described on case reports [2, 3] , but ectopic CRH-secreting NET observed by 68 Ga-DOTA-peptide PET/ CT has never been reported. 
